Joseph Sack, MD
Family Medicine · Wichita, KSNPI 1962475343
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $13,300 of the $21,023 with a category attached, or 63.3%. Amgen accounts for 73.0% of it on its own, with 19 other manufacturers making up the rest. Among family medicine clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 305 payments — averaging $68.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$15K
- Novo Nordisk$2K
- AstraZeneca$1K
- AbbVie$665
- Abbott$508
- Lilly USA, LLC$413
- plus $956 from 14 others
What the payments were for
- Speaking & faculty fees$13,30063%
- Travel & lodging$590%
- Food & beverage$7,59436%
- Education$700%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 94 | $15,351 |
| Novo Nordisk | 67 | $2,056 |
| AstraZeneca | 29 | $1,075 |
| AbbVie | 30 | $665 |
| Abbott | 25 | $508 |
| Lilly USA, LLC | 27 | $413 |
| GSK | 8 | $175 |
| Paratek Pharmaceuticals, Inc. | 3 | $155 |
| Radius Health, Inc. | 2 | $115 |
| Dexcom, Inc. | 1 | $101 |
| Pfizer | 6 | $90 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $84 |
| Sanofi-aventis U.S. LLC | 2 | $69 |
| Medicure Pharma Inc. | 1 | $47 |
| Currax Pharmaceuticals LLC | 2 | $41 |
| Eisai Inc. | 2 | $29 |
| Bayer | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Merck | 1 | $12 |
| Qorumpartners | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$13,668
- Wegovy$743
- Saxenda$493
- FARXIGA$363
- FreeStyle Libre$138
- FreeStyle Libre 2$128
- NUZYRA$125
- FASENRA$125
- QULIPTA$124
- AIRSUPRA$113
- UBRELVY$106
- Otezla$106
- Ozempic$103
- DEXCOM G7 GSS (161)$101
How this compares
$21,023 in reported general payments places this provider in the 95th percentile of 1,469 family medicine providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Repatha SureclickEvolocumab | 62 | $49,016 |
| FarxigaDapagliflozin Propanediol | 49 | $41,273 |
| MounjaroTirzepatide | 34 | $39,136 |
| EliquisApixaban | 39 | $32,894 |
| TrulicityDulaglutide | 32 | $31,007 |
| OxycontinOxycodone Hcl | 20 | $27,044 |
| OzempicSemaglutide | 22 | $20,961 |
| Xigduo XrDapaglifloz Propaned/Metformin | 22 | $17,854 |
| XareltoRivaroxaban | 21 | $11,408 |
| Potassium Chloride | 32 | $5,576 |
| LivaloPitavastatin Calcium | 11 | $3,543 |
| JanumetSitagliptin Phos/Metformin Hcl | 15 | $3,092 |
| Pulmicort FlexhalerBudesonide | 11 | $2,894 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 60 | $2,117 |
| Ezetimibe | 55 | $1,392 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $413 | $70,14366 claims |
| AstraZenecaFarxiga, Pulmicort Flexhaler | $1,075 | $44,16760 claims |
| PfizerEliquis | $90 | $32,89439 claims |
| Novo NordiskOzempic | $2,056 | $20,96122 claims |
| Kowa Pharmaceuticals America, Inc.Livalo | $13 | $3,54311 claims |
| MerckJanumet | $12 | $3,09215 claims |
| AbbVieSynthroid | $665 | $1,26013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,469 family medicine providers in Kansas.
Other family medicine in Wichita
- Mila MeansWichita$241K
- Cole GillenwaterWichita$62K
- Hai TruongWichita$25K
- Deborah OutwaterWichita$25K
- Scott StringfieldWichita$20K
- Mark LeikerWichita$20K
- Paul DavisWichita$18K
- Tara NeilWichita$16K
- William SimonWichita$14K
- Angela LeikerWichita$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.